Detalhe da pesquisa
1.
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552315
2.
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.
Arthritis Res Ther
; 24(1): 133, 2022 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659282
3.
Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.
Arthritis Rheumatol
; 72(1): 31-40, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469238
4.
Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study.
J Rheumatol
; 44(2): 142-146, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27909081
5.
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
Arthritis Rheumatol
; 69(9): 1751-1761, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28597609
6.
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab.
RMD Open
; 2(1): e000213, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27252893